Novavax
Budget
€200 — €0
EP Access
0
accredited persons
Staff
1
0.1 FTE
EU Grants
None
Mission & Goals
Novavax is a biotechnology company with a proven vaccine technology. We’re focused on developing our R&D assets and establishing partnerships to leverage the value of our technology to help protect health. With a strong scientific foundation, our technology includes both our recombinant protein-based nanoparticle and Matrix-M™ adjuvant. To learn more, please visit www.novavax.com
EU Legislative Interests
Novavax interacts with the EU institutions and engages on issues relevant to the company, including pandemic preparedness, vaccination and the promotion of policies supporting global health. Key policies and initiatives include: EU vaccination policies and the work of the European Health Emergency Preparedness and Response Authority, including the Strategy to support medical countermeasures against public health threats.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Vaccines Europe and the International Federation of Pharmaceutical Manufacturers and Associations
Organisation Members
none
Commissioner Meetings
No recorded meetings with EU commissioners.